Drug recall · January 26, 2022
Lexette recall
Why: CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50
- Lots / codes
Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023.
- Quantity
- 17,113 canisters
- Company
- Mayne Pharma Inc, Greenville, NC
- Distribution
- Nationwide within the United States
- Initiated
- January 14, 2022 · Voluntary: Firm initiated
- Classified
- January 19, 2022
- Reported
- January 26, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Halobetasol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.